期刊文献+

高密度脂蛋白胆固醇和冠心病相关性研究

下载PDF
导出
摘要 目的:探讨高密度脂蛋白胆固醇和冠心病相关性。方法:将我院收治的S5例冠G病忠者为设为观察组,另外基本健康者45例为时照蛆,测定两组患者的血清总胆圊醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL—C)、低密度脂蛋白胆固醇(LDL—C)等并对其进行分析。结果:观察组与对照组比较,HDL—c水平显著降低,LDL—C水平显著增高(P〈0.05),在冠心病与各危险因素的关系中,HDL—C与冠心病成负相关(值为-1.65,P〈0.05)。结论:HDL—C与冠心病发生发展及冠脉病变程度呈显著负相关,LDL—C是明显的独立危险因素。 objective to explore the high--density lipoprotein cholesterol and coronary heart disease. Our methods of 55 cases of patients with coronary heart disease is set to the observation group, another basic health in 45 cases as control group, determination of two sets of patients serum total cholesterol (TC) and triglycerides (TG), high--density lipoprotein cholesterol (hdl--c), low density lipoprotein cholesterol (LDL) -- C) and to ana- lyze it. Results compared with the control group, hdl--e leel was significantly lower levels were significantly higher LDL -- C ( P 〈0. 05), and coronary heart disease risk factors in the relationship, hdl--c negative correlation with coronary heart disease (& # Conclusion hdl--c with coronary heart disease, coronary disease is a significant negative correlation, LDL -- C is obvious independent risk factor. 61538; value for -- 1.65, P 〈0.05).
作者 吴茂花
出处 《医学信息(下旬刊)》 2010年第8期60-60,62,共2页 Medical information
关键词 高密度脂蛋白胆固醇 冠心病 相关性 high-- density lipoprotein cholesterol Coronarv heart disease : correlation
  • 相关文献

参考文献3

二级参考文献14

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3044
  • 2林虹,郭进,王风,林英忠,赵毅兰,李泓.不同冠状动脉病变程度患者肱动脉血管扩张程度和内皮素及一氧化氮观察[J].郑州大学学报(医学版),2006,41(4):658-659. 被引量:2
  • 3欧宁.老龄高血压患者脉压与冠状动脉粥样硬化狭窄程度的相关研究[J].实用临床医药杂志,2007,11(1):80-81. 被引量:20
  • 4Executive Summary of the Third Report of The National Cholesterol Education Program(NCEP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel Ⅲ.Final Report. Circulation, 2002,106:3143-3420.
  • 5Gardner CD, Winklerby MA, Fortmann SP. Population frequency distribution of non-high density lipoprotein cholesterol (Third National Health and Nutrition Examination survey [NHANES Ⅲ] 1988-1994). Am J Cardiol, 2000, 86:299-304.
  • 6Bitter V,Hocrdison R, Kelsey SF, et al. Non-high density lipoprotein cholesterol levels predict five-year outcome in the bypass angioplasty revascularization investigation (BARI). Circulation, 2002,106:2537-2542.
  • 7Forst PH, Havel RJ. Rational for use of non-high density lipoprotein cholesterol rather than low density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol, 1998, 81 (4A): 26B-31B.
  • 8Grundy SM. Low density lipoprotein, non-high density lipoprotein and apolipoprotein B as targets of lipid lowering therapy. Circulation, 2002, 106:2526-2529.
  • 9Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men [ J ]. JAMA, 2002, 288(21 ): 2709-2716
  • 10Ninomiya JK,Lltalien G,Criqui MH,et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey [ J ]. Circulation, 2004 ,109(1):42 -46.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部